Navigation Links
Agriculture & food production contribute up to 29 percent of global greenhouse gas emissions
Date:10/30/2012

COPENHAGEN (31 October, 2012)Feeding the world releases up to 17,000 megatonnes of carbon dioxide into the atmosphere annually, according to a new analysis released today by the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS). But while the emissions "footprint" of food production needs to be reduced, a companion policy brief by CCAFS lays out how climate change will require a complete recalibration of where specific crops are grown and livestock are raised.

Together, Climate Change and Food Systems (published in the 2012 Annual Review of Environment and Resources) and Recalibrating Food Production in the Developing World: Global Warming Will Change More Than Just the Climate (published by CCAFS), shed new light on the intertwining evolutions of climate change and the world's food system and their potential impact on humanity's relationship with food.

"Climate Change mitigation and adaptation are critical priorities. Farmers around the world, especially smallholder farmers in developing countries, need access to the latest science, more resources and advanced technology. This research serves as an urgent call for negotiators at the upcoming United Nations Framework Convention on Climate Change (UNFCCC) in Doha," said Bruce Campbell, CCAFS's program director.

We are coming to terms with the fact that agriculture is a critical player in climate change. Not only are emissions from agriculture much larger than previously estimated, but with weather records being set every month as regional climates adjust and reset, there is an urgent need for research that helps smallholder farmers adapt to the new normal. said Frank Rijsberman, the CEO of the CGIAR Consortium.

While previous studies have looked at the contribution of agriculture to emissions, Climate Change and Food Systems assesses the entire food system's emissions "footprint"in total somewhere between a fifth and th
'/>"/>

Contact: Dan Klotz
dklotz@burnesscommunications.com
301-280-5756

Michelle Geis
mgeis@burnesscommunications.com
301 2805712

Burness Communications
Source:Eurekalert


Page: 1 2 3 4

Related biology news :

1. Rice agriculture accelerates global warming, new research finds
2. Study shows hope of greater global food output, less environmental impact of agriculture
3. Clemson scholar receives top agriculture science award
4. U of M researchers Darwinian Agriculture explains how evolution can improve agriculture
5. Is rainfall a greater threat to Chinas agriculture than warming?
6. EyeLock Inc. Brings High-Tech Iris Biometric Production to Texas
7. Brainy beverage: Study reveals how green tea boosts brain cell production to aid memory
8. Clemson plant pathologist working to raise cucurbit yields, lower production costs
9. New process doubles production of alternative fuel while slashing costs
10. Cost-effective production of infrared lenses
11. Childhood obesity may affect timing of puberty, create problems with reproduction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2015)... CITY , June 25, 2015  Imagine a ... steps toward a healthier, happier life. That,s exactly what ... designed to do. The cutting-edge, portable health program provides ... real-life solutions to help improve your lifestyle and nutrition. ... awards dinner and gala Wednesday night, USANA,s THA was ...
(Date:6/24/2015)... YORK , June 24, 2015 This ... market, over the next six years. It contains an ... the industry, along with their impact from the short, ... It also discusses the industry, market, and technology trends ... that the need of concerned authorities to efficiently manage ...
(Date:6/24/2015)... 2015 Biometry authentication provider KeyLemon today ... solution one face in. Logo ... face in, entering the expanding biometric authentication market ... biometric answer to the password problem. With advanced ... with KeyLemon, one face in allows users to ...
Breaking Biology News(10 mins):@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... ancient mitochondrial DNA (mtDNA) has been used to establish ... the time before Christopher Columbus sailed to the Americas. ... BMC Genetics has used more detailed DNA ... family relationships and burial traditions of ancient Peru. ...
... SAN DIEGO With more than 1.7 million people ... to identify processes to limit inflammation and subsequent damage ... traumatic brain injury, leaving 85,000 with long-term disabilities and ... 5 million people live with disabilities caused by traumatic ...
... SAN DIEGO Heart failure is the most common ... of chronic high blood pressure, also known as hypertension. ... array of approaches aimed at preventing and treating high ... an anti-hypertensive drug, moxonidine, which acts on the imidazoline ...
Cached Biology News:Forensic science used to determine who's who in pre-Columbian Peru 2Estrogen hormone reveals protective ability after traumatic brain injury 2Second-generation drug used for hypertension aids heart function independent of blood pressure 2
(Date:7/1/2015)... Calif. , July 1, 2015   ... on the development of groundbreaking drugs to treat ... announced today that Robert G. Miller , ... at Sutter Health,s California Pacific Medical Center in San ... ALS Association for $1.5 million to help fund ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Apex Therapeutics ... BIO International Convention in Philadelphia, PA. , The presentation took place on ... outlined the plans for the development of APX3330 for the treatment of pancreatic cancer. ...
(Date:6/30/2015)... - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that ... approved the resolutions relating to: (i) a private ... at a price of $2.67 per unit (the ... one common share and 0.075358 common share purchase ... and (ii) the amendment to Resverlogix,s articles to ...
(Date:6/30/2015)... ... 30, 2015 , ... uBiome and OpenBiome Partner for Microbiome ... fecal microbiota transplantation in C. difficile patients. , SAN FRANCISCO, uBiome and OpenBiome ... microbiota transplantation (FMT) as a treatment for Clostridium difficile infections (C. diff). , ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3
... Morria Biopharmaceuticals,Plc, a biopharmaceutical company focused on ... ICH compliant Phase II equivalent,multi-center study of MRX-4 ... given as an intranasal spray formulation., The ... allergic,rhinitis patients outside of the local allergy season. ...
... new apoA1 measurement and apoB:apoA1 ratio to its, comprehensive cholesterol ... ... heart disease, BIRMINGHAM, Ala., Nov. 6 Atherotech, ... Test in booth No. 2918 at the American Heart Association,Scientific Sessions ...
... 6 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ) ... 30, 2008, the first quarter of the,company,s fiscal year ... September 30, 2008 was $3.6 million, compared to $3.9 ... expenses were $6.8 million,for the first quarter of fiscal ...
Cached Biology Technology:Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients 2Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients 3Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2008 2Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results 2Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results 3Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results 4Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results 5